Oracle's Twin Headwinds: A Delayed Gas Pipeline and a Legendary Bear Circling the Stock
Published on 08/15/2026 at 07:52 | Redaktion boerse-global.de
Oracle shareholders have been handed two uncomfortable reminders this week that the company's AI-driven growth story hinges on factors well beyond its control. The stock shed more than 4 percent on Friday as investors digested a six-month delay to a critical gas pipeline in New Mexico, while separately, famed investor Michael Burry has been quietly expanding his bearish bets against the software giant.
The Green Chile pipeline, operated by an Energy Transfer subsidiary, was slated to supply natural gas to Oracle's Jupiter data center complex — a project carrying a staggering $165 billion price tag. In a regulatory filing, the operator pushed the expected in-service date back to February 1, 2027. On the surface, half a year hardly seems like a catastrophe for a company with Oracle's scale. But it lands at a delicate moment when the company's entire valuation thesis rests on the timely delivery of massive physical infrastructure.
The Balance Sheet Tightrope
Oracle's financial position leaves little margin for error. The company has earmarked $70 billion in capital expenditures for the current fiscal year, funded in part by roughly $40 billion in fresh debt and equity — including an already announced $20 billion share offering. Total debt now stands at $164 billion, pushing the debt-to-equity ratio to approximately 3.9. In plain terms, Oracle owes nearly four times what its shareholders own outright.
The operational picture, however, remains robust. Revenue for fiscal 2026 climbed 17 percent to a record $67.4 billion, with cloud revenues surging 39 percent to $34.0 billion. The company's remaining performance obligations exploded 363 percent to $638 billion, largely fueled by blockbuster AI contracts. Management is guiding to $90 billion in revenue for the current fiscal year — a 34 percent increase on a constant-currency basis.
Yet the flip side is stark: free cash flow came in at negative $23.7 billion last fiscal year, a direct consequence of the infrastructure spending spree. Insider selling has added another layer of unease, with executives offloading $63.7 million worth of shares over the past three months without any corresponding purchases.
Should investors sell immediately? Or is it worth buying Oracle?
Burry's Growing Conviction
The skepticism isn't confined to the options market. Michael Burry, the investor immortalized in "The Big Short," has expanded his short position in Oracle, building on trades first disclosed on August 7 at $144.63 per share. His latest additions came with the stock trading around $152. Burry's thesis centers on a looming oversupply of AI computing capacity by 2028, compounded by Oracle's heavy debt load and off-balance-sheet obligations.
UBS analysts have echoed some of these concerns. On August 7, they trimmed their price target from $285 to $245 while maintaining a "Buy" rating, explicitly flagging risks tied to rising AI infrastructure spending and the uncertain returns on invested capital.
The stock's trajectory reflects this mounting caution. Oracle currently trades roughly 56 percent below its 52-week high, reached last September. Friday's decline left the shares at €130.42, down 3.8 percent in European trading.
Diversification as a Counterweight
Management hasn't been idle on the strategic front. The expanded partnership with Amazon Web Services brings Oracle AI Database@AWS to 22 regions, with usage-based pricing for Exadata capacity — a move designed to capture customers modernizing Oracle workloads within AWS's ecosystem. A multi-year collaboration with Quantinuum will integrate that firm's Helios quantum computer into Oracle Cloud Infrastructure, giving customers access to the commercially launched machine from November.
Additional wins include a $400 million contract with CACI for HR modernization and an expansion of Oracle Health into Ontario hospitals. The Pentagon also awarded Oracle a five-year enterprise software contract worth up to $7 billion earlier this month.
At the same time, Oracle is trimming headcount to manage costs, with reports suggesting some teams could face double-digit percentage reductions ahead of the second fiscal quarter starting September 1.
A Fragile Equation
The pipeline delay is more than an isolated logistical hiccup — it crystallizes the tension at the heart of Oracle's current strategy. The company is simultaneously juggling explosive growth metrics, deeply negative cash flow, and a balance sheet with little room for further shocks. The diversification efforts suggest management recognizes these vulnerabilities and is working to mitigate them. But as long as external dependencies like gas pipelines dictate the timeline, the stock remains exposed to precisely the kind of setbacks that surfaced this week — no matter how robust the order book looks on paper.
Ad
Oracle Stock: New Analysis - 15 August
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
